Pharmacological treatments for adults with post-traumatic stress disorder: A network meta-analysis of comparative efficacy and acceptability

奎硫平 舍曲林 文拉法辛 利培酮 托吡酯 医学 安慰剂 氟西汀 随机对照试验 精神科 内科学 帕罗西汀 心理学 精神分裂症(面向对象编程) 焦虑 癫痫 抗抑郁药 受体 替代医学 血清素 病理
作者
Gabriela de Moraes Costa,Fabrício Batistin Zanatta,Patrícia Klarmann Ziegelmann,Alcina Juliana Soares Barros,Carlos Fernando Mello
出处
期刊:Journal of Psychiatric Research [Elsevier BV]
卷期号:130: 412-420 被引量:25
标识
DOI:10.1016/j.jpsychires.2020.07.046
摘要

The purpose of this study was to compare efficacy and acceptability among drug treatments for adults with post-traumatic stress disorder (PTSD) through a systematic review, random-effects pairwise and network meta-analyses.Double-blind randomized controlled trials comparing pharmacological interventions for adults with PTSD were searched from database inception through Aug. 28, 2018, on Cochrane (Central), Embase, LILACS, PILOTS, PsycINFO, PubMed, and Web of Science. Clinical trial registries and the websites of pharmaceutical companies were also searched. The GRADE system was used to assess the quality of the evidence.The systematic review included 58 studies comprising 6766 patients randomized to 26 different interventions. Regarding efficacy, topiramate (SMD = -0.57; 95%CrI: -1.07,-0.10), risperidone (SMD = -0.53; 95%CrI: -0.93,-0.15), quetiapine (SMD = -0.59; 95%CrI: -1.06,-0.11), paroxetine (SMD = -0.35; 95%CrI: -0.48,-0.21), venlafaxine (SMD = -0.25; 95%CrI: -0.44,-0.05), fluoxetine (SMD = -0.28; 95%CrI: -0.46,-0.08), and sertraline (SMD = -0.21; 95%CrI: -0.33,-0.09) outperformed placebo. Moreover, phenelzine (RR = 3.39; 95%CrI: 1.43,11.09), lamotrigine (RR = 4.39; 95%CrI: 1.18,26.38), and fluoxetine (RR = 1.28%CrI: 1.01,1.59) outperformed placebo in terms of acceptability.The NMA supports topiramate, risperidone, quetiapine, paroxetine, venlafaxine, fluoxetine and sertraline as effective pharmacological choices for the treatment of PTSD. Quetiapine and topiramate have the shortcoming of relying on a few small studies, but the clinically meaningful change in symptoms is noteworthy and merits further investigation. Among the pharmacological treatments with evidence of efficacy compared to placebo, fluoxetine achieved a relatively high rank regarding acceptability. To the best of our knowledge, this is the largest contemporary NMA on the subject and the addition of new medications is an important extension of previous meta-analyses, enabling a larger number of drug comparisons.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
能能鹤完成签到,获得积分10
刚刚
CodeCraft应助zhaoyali采纳,获得10
1秒前
1秒前
YUKONG完成签到 ,获得积分10
1秒前
1秒前
cookangdavid发布了新的文献求助10
2秒前
123发布了新的文献求助10
2秒前
will完成签到,获得积分10
2秒前
3秒前
SYLH应助科研通管家采纳,获得10
3秒前
无花果应助科研通管家采纳,获得10
3秒前
DD应助科研通管家采纳,获得10
3秒前
3秒前
共享精神应助科研通管家采纳,获得10
3秒前
sevenvictory应助科研通管家采纳,获得10
4秒前
852应助科研通管家采纳,获得10
4秒前
SYLH应助科研通管家采纳,获得10
4秒前
鱼会淹死吗应助科研通管家采纳,获得100
4秒前
4秒前
4秒前
4秒前
4秒前
大模型应助科研通管家采纳,获得10
4秒前
wwc完成签到,获得积分10
4秒前
4秒前
4秒前
SYLH应助科研通管家采纳,获得10
4秒前
昵称被注册完了完成签到,获得积分10
5秒前
5秒前
LL完成签到 ,获得积分10
5秒前
5秒前
庸人何必自扰完成签到,获得积分10
6秒前
一禾生发布了新的文献求助10
6秒前
123456完成签到,获得积分10
6秒前
岩追研发布了新的文献求助10
6秒前
7秒前
7秒前
7秒前
龙仔子完成签到,获得积分10
7秒前
英姑应助为神指路采纳,获得10
7秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3974643
求助须知:如何正确求助?哪些是违规求助? 3519094
关于积分的说明 11196979
捐赠科研通 3255182
什么是DOI,文献DOI怎么找? 1797700
邀请新用户注册赠送积分活动 877100
科研通“疑难数据库(出版商)”最低求助积分说明 806130